Dedicated to restoring the spirit of R&D incentives in the Orphan Drug Act.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2023 | LEAVITT PARTNERS, LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2023 | LEAVITT PARTNERS, LLC |
4th Quarter (Oct 1 - Dec 31) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| LEAVITT PARTNERS, LLC | 11 | — |
| Issue | Activities |
|---|---|
| Health Issues | 11 |